本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bionomics Limited

0.2531
0.0000
成交量:- -
成交额:268.28万
市值:494.24万
市盈率:-0.28
高:0.2531
开:0.2531
低:0.2531
收:0.2531
52周最高:1.60
52周最低:0.1770
股本:1,952.73万
流通股本:1,673.15万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9166
每股收益(LYR):-1.5513
净资产收益率:-55.39%
总资产收益率:-41.41%
市净率:0.29
市盈率(LYR):-0.16

数据加载中...

2024/12/23

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report
2024/12/12

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/10

重要事件披露

Form 8-K - Current report
2024/10/07

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/02

重要事件披露

Form 8-K - Current report
2024/09/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/07/16

重要事件披露

Form 8-K - Current report
2024/06/24

SEC问询函

Form CORRESP - Correspondence
2024/06/18

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]